For the Inventor, By the Inventor

Enter assignee name

Sclavo Spa

USPTO Granted Patents = 44

CIPO Patents = 1

Forward Citations = 828

Loading Chart...

Loading Chart...

96 inventors (with patents filed for the assignee):

Antonio S Verdini (9 out of 35 patents)

Paolo Tarli (4 out of 8 patents)

Rino Rappuoli (3 out of 82 patents)

4. Massimo Pinori (3 out of 13 patents)

5. Luciano Nencioni (3 out of 5 patents)

6. Alessandro Sisto (3 out of 15 patents)

7. Marzia Monica Giuliani (3 out of 28 patents)

8. Mario F Tecce (3 out of 5 patents)

9. Felice Centini (3 out of 6 patents)

10. Franco Cardinali (3 out of 3 patents)

11. Giuseppe C Viscomi (3 out of 3 patents)

12. Diana Boraschi (3 out of 3 patents)

13. Paolo Fabrizi (3 out of 3 patents)

14. Alessandro Tabacco (3 out of 4 patents)

15. Claudio Fuganti (2 out of 15 patents)

Core Competencies:

Chlamydia Trachomatis

Pertussis Toxin

Recombinant Proteins

Synthetic Peptides

Immunological Activity

Vaccine Composition

Retro-Inverso Peptides

Non-Invasive Monitoring

Glycoproteinic Conjugates

Microorganism Identification

Intrarectal Pharmaceutical Composition

Light Photometer

44 patents: Sort by Forward Citations

1. 6096519 - Chlamydia trachomatis serotype D proteins (2000-08-01),

2. 5622706 - Cloning and sequencing of the gene which codes for a new pilinic subunit (1997-04-22),

3. 5432082 - Expression and secretion vector in yeasts, useful for preparing (1995-07-11),

4. 5427788 - Pertussis toxin and use in vaccines (1995-06-27),

5. 5378365 - Process for the isolation of highly purified factors IX, X and II from (1995-01-03),

6. 5300427 - Buffer solutions containing collagenase, their preparation and use for (1994-04-05),

7. 5284937 - Process for the extraction and purification of human recombinant gamma (1994-02-08),

8. 5279944 - Method and reagent composition for the determination of alanine (1994-01-18),

9. 5259951 - Process for the purification of factor VIII and factor VIII obtained by (1993-11-09),

10. 5244655 - Process for the purification of recombinant human beta interferon, beta (1993-09-14),

11. 5229367 - Antiinflammatory peptide derived from human lipocortin V (1993-07-20),

12. 5219988 - Gem-diamino derivatives and their use in the synthesis of retro-inverso (1993-06-15),

13. 5218089 - Retro-inverso analogues of thymopentin and the method for their synthesis (1993-06-08),

14. 5206164 - DNA encoding a synthetic peptide endowed with immunological activity and (1993-04-27),

15. 5206014 - Synthetic nonapeptide for use as an adjuvant (1993-04-27),

Sclavo Spa is a leading pharmaceutical company founded in 1920. With a focus on research, development, and production of innovative medicines, Sclavo aims to improve the health and well-being of individuals globally. Their extensive product portfolio includes vaccines, antibiotics, antivirals, and other specialty pharmaceuticals. Committed to quality and customer satisfaction, Sclavo collaborates with healthcare professionals and institutions worldwide to address pressing medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

44 Patents

#7 in

#187 in Italy

#15,298 in the World

Sclavo Spa

Forward Citations = 828

96 inventors:

Antonio S Verdini (9 out of 35 patents)

Paolo Tarli (4 out of 8 patents)

Rino Rappuoli (3 out of 82 patents)

4. Massimo Pinori (3 out of 13 patents)

5. Luciano Nencioni (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…